Restated Indications for Use modify the weight range for the EZ-IO® 25 mm Needle Set for patients 3 kg or over
Wayne, PA - Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced FDA 510(k) clearance for restated Indications for Use of the EZ-IO® Vascular Access System. The EZ-IO® 25 mm Needle Set is now indicated for patients 3 kg or over.Teleflex recently announced its acquisition of Vidacare Corporation, developer of the EZ-IO® Vascular Access System. Vidacare is a leading provider of intraosseous (IO), or inside the bone access devices.
“In my clinical work in a free-standing, academic pediatric emergency department and level 1 trauma center, as well as in a large community hospital emergency department, rapid identification and treatment of serious conditions is paramount,” states Mark L. Waltzman, MD, FAAP, Chief of Pediatrics, South Shore Hospital, Assistant Professor, Department of Pediatrics at Harvard Medical School and affiliation with the Division of Emergency Medicine at Boston Children’s Hospital. Dr. Waltzman is also a paid consultant for Teleflex. “The restated indication for the EZ-IO® 25 mm Needle Set to be used in patients 3 kg or over will help to avoid confusion and streamline care. Clinicians now will simply assess the tissue depth and choose the correct needle size. This is something we ‘in the trenches’ clinicians have requested from the company and I am gratified they have heard our feedback and pushed for this change.”
New weight ranges for the EZ-IO® Vascular Access System are now as follows:
Description: | Weight Classification | |||||
EZ-IO® 45 mm Needle | 40 kg or over | |||||
EZ-IO® 25 mm Needle | 3 kg or over | |||||
EZ-IO® 15 mm Needle | 3 – 39 kg |
“As part of our fight for zero complications in vascular access, we are committed to continuously improving our technologies, enhancing our training and educational initiatives, and partnering with healthcare professionals to provide innovative solutions for treating difficult vascular access patients with the EZ-IO® Vascular Access System,” states Jay White, President and General Manager, Vascular Access Division, Teleflex. “We’re excited about the restated Indications for Use, because we’ve made it even easier for clinicians to select the right needle for their patient.”
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Wayne, PA, Teleflex employs approximately 11,400 people worldwide and serves healthcare providers in more than 150 countries. Additional information about Teleflex can be obtained from the company’s website at teleflex.com.